You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《即日市評》恆指「三連跌」金融股弱 藥明系彈
受金融股及科網股跌勢拖累,港股今日持續向下。烏克蘭局勢持續緊張,德總理將往俄國斡旋,美股道指昨跌0.5%,納指微跌,執筆之時美國十年期國債孳息率升至2.041釐,美匯指數跌至96.03。俄羅斯部分軍隊在演習後返回基地,美股道指期貨最新升323點或1%,納指期貨最新升1.6%。人行進行3,000億人幣MLF,上證綜指全日升17點或0.5%收3,446點,深證成指升1.7%,內地創業板指數升3.1%,滬深兩市成交額共8,275億人民幣。 恆指低開98點,早段曾升13點高見24,570點,其後再度向下,一度低見24,219點曾跌336點,最終全日跌200點或0.82%,收24,355點,連跌三個交易日(累跌568點或2.3%);國指全日跌90點或1.05%,收8,528點;恆生科技指數跌11點或0.22%,收5,490點。大市全日成交總額1,141.39億元,滬港通南下交易淨流出10.55億元人民幣,深港通南下交易淨流入11.37億元人民幣。 【恆指三連跌 金融股造淡】 中資金融股受壓,建行(00939.HK)、農行(01288.HK)、工行(01398.HK)及中行(03988.HK)各跌2.7%至2.9%,郵儲行(01658.HK)跌4.5%,交行(03328.HK)及招行(03968.HK)各跌2.3%至2.5%。內險股亦普遍下跌,中國太平(00966.HK)跌6%,中國平安(02318.HK)及國壽(02628.HK)各下滑3.5%。 收租股靠穩,希慎(00014.HK)升0.2%,九龍倉置業(01997.HK)漲1.8%。瑞銀髮表報告,料市場仍未反映任何進一步收緊社交距離措施。參考2020年底一波疫情,該行料新一輪社交距離措施或維持逾90日。倘發生大規模封城,料零售收租業主提供額外租金寬免,對短期股價構成進一步壓力。考慮2020年7月29至30日全日堂食被禁時期,料本港零售收租股將面對12%至22%額外下行敞口。另該行料零售商場人流將進一步減少35%,2至3月零售銷售將面對18%至23%下行空間。 【市寬略改善 藥明系彈高】 港股今日市寬略改善,主板股票的升跌比率爲18比22(上日爲12比29),恆指成份股今日26只股份上升,下跌股份36只,升跌比率爲40比56(上日爲16比80);大市今日錄沽空166億元,佔可沽空股份成921億元的18.023%(上日爲20.016%)。 醫藥股逆市彈高,信達生物(01801.HK)升16.8%,藥明生物(02269.HK)及藥明康德(02359.HK)各升10.1%及12.1%。 裏昂發表報告指出,美國食品及藥物管理局(FDA)於2月10日召開腫瘤藥物諮詢委員會(ODAC),以14票贊成對1票反對下,通過要求信達生物信迪利單抗注射液的新藥進行額外臨牀試驗,意味着不太可能於3月討論「處方藥使用者付費法」前獲得上市批準,符合市場預期。該行指出,信達生物管理層對公司全球化目標不變。該行將其2021至2023財年的收入預測分別下調2.9%、2.3%及2.7%,料期內淨虧損預測分別擴大6.3%、11.5%及49.1%,目標價由90.1元削至47元,維持「買入」評級。(wl/u) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account